NO970130L - Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener - Google Patents

Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener

Info

Publication number
NO970130L
NO970130L NO970130A NO970130A NO970130L NO 970130 L NO970130 L NO 970130L NO 970130 A NO970130 A NO 970130A NO 970130 A NO970130 A NO 970130A NO 970130 L NO970130 L NO 970130L
Authority
NO
Norway
Prior art keywords
haptens
carrier molecules
marker groups
embedded marker
oligomeric carrier
Prior art date
Application number
NO970130A
Other languages
English (en)
Other versions
NO970130D0 (no
Inventor
Hans-Peter Josel
Andreas Finke
Rupert Herrmann
Eva Hoess
Andreas Marschall
Christoph Seidel
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4430998A external-priority patent/DE4430998A1/de
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of NO970130L publication Critical patent/NO970130L/no
Publication of NO970130D0 publication Critical patent/NO970130D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/743—Steroid hormones
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO970130A 1994-07-25 1997-01-10 Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener NO970130D0 (no)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
DE4426276 1994-07-25
DE4430998A DE4430998A1 (de) 1994-07-25 1994-08-31 Metallchelat-markierte Peptide
DE4430973A DE4430973A1 (de) 1994-07-25 1994-08-31 Hapten-markierte Peptide
DE4439345A DE4439345A1 (de) 1994-07-25 1994-11-04 Oligomere Trägermoleküle mit definiert eingebauten Markierungsgruppen und Haptenen
PCT/EP1995/002915 WO1996003650A1 (de) 1994-07-25 1995-07-24 Oligomere trägermoleküle mit definiert eingebauten markierungsgruppen und haptenen

Publications (2)

Publication Number Publication Date
NO970130L true NO970130L (no) 1997-01-10
NO970130D0 NO970130D0 (no) 1997-01-10

Family

ID=27436022

Family Applications (1)

Application Number Title Priority Date Filing Date
NO970130A NO970130D0 (no) 1994-07-25 1997-01-10 Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener

Country Status (12)

Country Link
EP (1) EP0774119B1 (no)
JP (1) JP3923076B2 (no)
CN (1) CN1178062C (no)
AT (1) ATE261122T1 (no)
CA (1) CA2195752C (no)
DK (1) DK0774119T3 (no)
ES (1) ES2217282T3 (no)
FI (1) FI970299L (no)
NO (1) NO970130D0 (no)
NZ (1) NZ290810A (no)
PT (1) PT774119E (no)
WO (1) WO1996003650A1 (no)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030078416A1 (en) * 1996-04-30 2003-04-24 Yitzhak Tor Substituted phenanthrolines
US6081734A (en) 1996-08-16 2000-06-27 Roche Diagnostics Gmbh Monitoring system for the regular intake of a medicament
FR2955111B1 (fr) 2010-01-12 2013-05-31 Biomerieux Sa Procede de preparation de composes polybiotinyles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE42317T1 (de) * 1983-07-29 1989-05-15 Henning Berlin Gmbh Voraktivierte kunststoffoberflaechen zur immobilisierung von organisch-chemischen und biologischen materialien, verfahren zur herstellung und verwendung derselben.
US4748111A (en) * 1984-03-12 1988-05-31 Molecular Diagnostics, Inc. Nucleic acid-protein conjugate used in immunoassay
EP0155224A3 (en) * 1984-03-15 1987-05-06 CHROMAGENICS, Inc. Solid-borne complex bearing chromagen responsive functionality for antibody, antigen, receptor, or ligand detection
DK365785A (da) * 1984-09-17 1986-03-18 Hoffmann La Roche Metalcomplexer
US5106762A (en) * 1990-04-20 1992-04-21 Georgetown University Ligand-label conjugates which contain polyoxoanions of sulfur or phosphorus
CA2064972A1 (en) * 1991-04-03 1992-10-04 John Joseph Rejman Immunoassay for immunoglobulins

Also Published As

Publication number Publication date
AU3164995A (en) 1996-02-22
DK0774119T3 (da) 2004-07-12
WO1996003650A1 (de) 1996-02-08
CN1178062C (zh) 2004-12-01
JPH10506708A (ja) 1998-06-30
CN1153555A (zh) 1997-07-02
NZ290810A (en) 1998-01-26
FI970299A0 (fi) 1997-01-24
NO970130D0 (no) 1997-01-10
FI970299A7 (fi) 1997-01-24
EP0774119A1 (de) 1997-05-21
CA2195752C (en) 2010-10-26
EP0774119B1 (de) 2004-03-03
JP3923076B2 (ja) 2007-05-30
FI970299L (fi) 1997-01-24
AU682278B2 (en) 1997-09-25
PT774119E (pt) 2004-07-30
CA2195752A1 (en) 1996-02-08
ES2217282T3 (es) 2004-11-01
ATE261122T1 (de) 2004-03-15

Similar Documents

Publication Publication Date Title
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
PL343245A1 (en) Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses
DE69935986D1 (de) Streptococcus pneumoniae proteine und nukleinsäuren
ES520692A0 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
ATE317441T1 (de) Cathepsin-02-protease
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
DE69021742D1 (de) Verfahren zum Nachweis von kleinzelligem Carzinom und die Verwendung von Sequenzen, die Acylpeptid-Hydrolase codieren, für diesen zweck.
ATE456799T1 (de) Verfahren zum identifizieren von präneoplastischen und neoplastischen stadien in säugern
UY26266A1 (es) Antigeno asociado con tumores (r11) ley 17164
DE69728897D1 (de) Saeugetierchemokine
NO970130L (no) Oligomere bærermolekyler med definerte, innebygde markörgrupper og haptener
ES2236703T3 (es) Uso de metodos para identificar oligopeptidos de señal hidrofilos.
ATE122723T1 (de) Retinoblastoma-genprodukt-antikörper und deren verwendungen.
ATE197645T1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
ATE280229T1 (de) Enterotoxine von shigella flexneri 2a
GB9810084D0 (en) Proteins
WO2005037228A3 (en) Halogen phosphonate monoesters
DE60230051D1 (de) Nukleinsäure und entsprechendes protein mit der bezeichnung 121p2a3 zur behandlung und zum nachweis von krebs
UA31082A (uk) Спосіб прискорення біологічного дослідження на туберкульоз

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application